Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 1
1987 2
1988 2
1989 4
1991 1
1992 1
1993 2
1994 1
1995 3
1996 2
1997 4
1998 6
1999 8
2000 7
2001 5
2002 6
2003 10
2004 12
2005 14
2006 17
2007 8
2008 10
2009 18
2010 21
2011 21
2012 22
2013 30
2014 21
2015 33
2016 32
2017 21
2018 25
2019 44
2020 37
2021 27
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

436 results
Results by year
Filters applied: . Clear all
Page 1
Substituting whole grains for refined grains in a 6-wk randomized trial has a modest effect on gut microbiota and immune and inflammatory markers of healthy adults.
Vanegas SM, Meydani M, Barnett JB, Goldin B, Kane A, Rasmussen H, Brown C, Vangay P, Knights D, Jonnalagadda S, Koecher K, Karl JP, Thomas M, Dolnikowski G, Li L, Saltzman E, Wu D, Meydani SN. Vanegas SM, et al. Among authors: jonnalagadda s. Am J Clin Nutr. 2017 Mar;105(3):635-650. doi: 10.3945/ajcn.116.146928. Epub 2017 Feb 8. Am J Clin Nutr. 2017. PMID: 28179226 Free PMC article. Clinical Trial.
Aldo-Keto Reductases and Cancer Drug Resistance.
Penning TM, Jonnalagadda S, Trippier PC, Rižner TL. Penning TM, et al. Among authors: jonnalagadda s. Pharmacol Rev. 2021 Jul;73(3):1150-1171. doi: 10.1124/pharmrev.120.000122. Pharmacol Rev. 2021. PMID: 34312303 Free PMC article. Review.
Endoscopic bariatric therapies.
ASGE Bariatric Endoscopy Task Force; ASGE Technology Committee, Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, Kumar N, Larsen M, Sullivan S, Thompson CC, Banerjee S. ASGE Bariatric Endoscopy Task Force, et al. Among authors: jonnalagadda s. Gastrointest Endosc. 2015 May;81(5):1073-86. doi: 10.1016/j.gie.2015.02.023. Epub 2015 Mar 28. Gastrointest Endosc. 2015. PMID: 25828245 Review. No abstract available.
Advances in bioprinting using additive manufacturing.
Singh M, Jonnalagadda S. Singh M, et al. Among authors: jonnalagadda s. Eur J Pharm Sci. 2020 Feb 15;143:105167. doi: 10.1016/j.ejps.2019.105167. Epub 2019 Nov 26. Eur J Pharm Sci. 2020. PMID: 31778785 Review.
Bruton's Tyrosine Kinase Targeting in Multiple Myeloma.
Von Suskil M, Sultana KN, Elbezanti WO, Al-Odat OS, Chitren R, Tiwari AK, Challagundla KB, Srivastava SK, Jonnalagadda SC, Budak-Alpdogan T, Pandey MK. Von Suskil M, et al. Among authors: jonnalagadda sc. Int J Mol Sci. 2021 May 27;22(11):5707. doi: 10.3390/ijms22115707. Int J Mol Sci. 2021. PMID: 34071917 Free PMC article. Review.
Machine learning for metabolic engineering: A review.
Lawson CE, Martí JM, Radivojevic T, Jonnalagadda SVR, Gentz R, Hillson NJ, Peisert S, Kim J, Simmons BA, Petzold CJ, Singer SW, Mukhopadhyay A, Tanjore D, Dunn JG, Garcia Martin H. Lawson CE, et al. Among authors: jonnalagadda svr. Metab Eng. 2021 Jan;63:34-60. doi: 10.1016/j.ymben.2020.10.005. Epub 2020 Nov 19. Metab Eng. 2021. PMID: 33221420 Free article. Review.
Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma.
Al-Odat O, von Suskil M, Chitren R, Elbezanti W, Srivastava S, Budak-Alpddogan T, Jonnalagadda S, Aggarwal B, Pandey M. Al-Odat O, et al. Among authors: jonnalagadda s. Front Pharmacol. 2021 Jul 19;12:699629. doi: 10.3389/fphar.2021.699629. eCollection 2021. Front Pharmacol. 2021. PMID: 34349655 Free PMC article. Review.
436 results